LOPRESSIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lopressidone, and when can generic versions of Lopressidone launch?
Lopressidone is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in LOPRESSIDONE is chlorthalidone; metoprolol tartrate. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; metoprolol tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOPRESSIDONE?
- What are the global sales for LOPRESSIDONE?
- What is Average Wholesale Price for LOPRESSIDONE?
Summary for LOPRESSIDONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Patent Applications: | 4,083 |
DailyMed Link: | LOPRESSIDONE at DailyMed |
US Patents and Regulatory Information for LOPRESSIDONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-001 | Dec 31, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-002 | Dec 31, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOPRESSIDONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-001 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-002 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOPRESSIDONE
See the table below for patents covering LOPRESSIDONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 578507 | ⤷ Sign Up | |
Netherlands | 7101885 | ⤷ Sign Up | |
South Africa | 7100682 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |